{"id":"https://openalex.org/W66790374","doi":null,"title":"Utiliza\u00e7\u00e3o da metformina como f\u00e1rmaco hipolipemiante em doentes n\u00e3o diab\u00e9ticos","display_name":"Utiliza\u00e7\u00e3o da metformina como f\u00e1rmaco hipolipemiante em doentes n\u00e3o diab\u00e9ticos","publication_year":2004,"publication_date":"2004-10-01","ids":{"openalex":"https://openalex.org/W66790374","mag":"66790374"},"language":"pt","primary_location":{"id":"pmh:oai:estudogeral.sib.uc.pt:10316/11847","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10316/11847","pdf_url":"http://hdl.handle.net/10316/11847","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"http://purl.org/coar/resource_type/c_6501"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10316/11847","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025385730","display_name":"Patr\u00edcia Dias","orcid":"https://orcid.org/0000-0002-1158-5417","observed_orcids":["https://orcid.org/0000-0002-1158-5417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patr\u00edcia Dias","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1158-5417","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060813280","display_name":"Rita Reis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita Reis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007378075","display_name":"Francisco Raimundo Albuquerque Parente","orcid":"https://orcid.org/0000-0001-9827-6707","observed_orcids":["https://orcid.org/0000-0001-9827-6707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francisco Parente","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9827-6707","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077031411","display_name":"J. Manuel Silva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Manuel Silva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Jos\u00e9 J. G. Moura","orcid":"https://orcid.org/0000-0002-4726-2388","observed_orcids":["https://orcid.org/0000-0002-4726-2388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 J. G. Moura","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4726-2388","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00837893,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.03240000084042549,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8569999933242798},{"id":"https://openalex.org/keywords/non-diabetic-patients","display_name":"non-diabetic patients","score":0.968999981880188},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9100000262260437},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9319999814033508},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.8199999928474426},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9789999723434448},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9490000009536743}],"concepts":[{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.9213061332702637},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8961936235427856},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6453607082366943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6371752023696899},{"id":"https://openalex.org/C3020110884","wikidata":"https://www.wikidata.org/wiki/Q695416","display_name":"Outpatient clinic","level":2,"score":0.553030788898468},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.5450955629348755},{"id":"https://openalex.org/C2777090001","wikidata":"https://www.wikidata.org/wiki/Q5308827","display_name":"Drug-na\u00efve","level":3,"score":0.5005025863647461},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.4710283875465393},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4576586186885834},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3915938436985016},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3468247056007385},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33529388904571533},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16749799251556396}],"mesh":[],"locations_count":5,"locations":[{"id":"pmh:oai:estudogeral.sib.uc.pt:10316/11847","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10316/11847","pdf_url":"http://hdl.handle.net/10316/11847","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:rihuc.huc.min-saude.pt:10400.4/422","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.4/422","pdf_url":"http://hdl.handle.net/10400.4/422","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:estudogeral.uc.pt:10316/11847","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10316/11847","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:oai.revista.spmi.pt:article/1763","doi":null,"is_oa":false,"landing_page_url":"https://revista.spmi.pt/index.php/rpmi/article/view/1763","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Internal Medicine; Vol. 11 No. 4 (2004): Outubro/ Dezembro; 178-182","raw_type":"journal article"},{"id":"mag:66790374","doi":null,"is_oa":false,"landing_page_url":"https://estudogeral.sib.uc.pt/bitstream/10316/11847/1/Utiliza%c3%a7%c3%a3o%20da%20metformina%20como%20f%c3%a1rmaco%20hipolipemiante.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:estudogeral.sib.uc.pt:10316/11847","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10316/11847","pdf_url":"http://hdl.handle.net/10316/11847","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"http://purl.org/coar/resource_type/c_6501"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W66790374.pdf","grobid_xml":"https://content.openalex.org/works/W66790374.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1873924216","https://openalex.org/W1879688080","https://openalex.org/W1963764475","https://openalex.org/W1982118230","https://openalex.org/W1992386743","https://openalex.org/W1999429833","https://openalex.org/W2039851346","https://openalex.org/W2046503553","https://openalex.org/W2062470779","https://openalex.org/W2085696762","https://openalex.org/W2135623134","https://openalex.org/W2158822657","https://openalex.org/W2472267654"],"related_works":["https://openalex.org/W7058633459","https://openalex.org/W3000694081","https://openalex.org/W2433856939","https://openalex.org/W192310773","https://openalex.org/W2280013044","https://openalex.org/W3016041816","https://openalex.org/W2135623134","https://openalex.org/W2089662453","https://openalex.org/W2472267654","https://openalex.org/W2040536455"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,10,20,45,54,58,135,158],"effect":[4],"of":[5,13,22,61,66,69,87,96,103,157],"therapy":[6],"with":[7,35,64,123,152],"metformin":[8,36,124],"on":[9],"lipid":[11,39,46],"profile":[12,47],"dyslipidemic,":[14],"non-diabetic":[15,23,70,118,147],"patients.":[16],"METHODS:":[17],"We":[18,56],"studied":[19],"subgroup":[21],"patients":[24,72,119,151],"from":[25],"our":[26],"Lipidology":[27],"/":[28],"Dyslipidemia":[29],"outpatient":[30],"clinic":[31],"who":[32,120],"were":[33,121],"treated":[34,73,122],"as":[37,90,92,141],"first":[38],"lowering":[40],"drug":[41,145],"(n=17),":[42],"and":[43,49,99,130,154],"evaluated":[44],"before":[48],"3":[50],"months":[51,77],"after":[52,78],"introducing":[53,79],"drug.":[55],"compared":[57],"baseline":[59],"characteristics":[60],"this":[62],"group":[63],"those":[65],"a":[67,83,93,100,142],"sample":[68],"dyslipidemic":[71],"differently.":[74],"RESULTS:":[75],"Three":[76],"metformin,":[80],"there":[81],"was":[82],"41,8%":[84],"significant":[85],"reduction":[86,95],"triglycerides":[88,133],"(p=0.006),":[89],"well":[91],"10.4%":[94],"total":[97],"cholesterol":[98,113,129],"5.9%":[101],"raise":[102],"HDL":[104,128],"cholesterol,":[105],"which":[106],"did":[107,114],"not":[108,115],"reach":[109],"statistical":[110],"significance.":[111],"LDL":[112],"vary":[116],"significantely.The":[117],"had":[125],"lower":[126],"mean":[127,132],"higher":[131],"than":[134],"other":[136,155],"non-diabetics.":[137],"CONCLUSION:":[138],"Metformin":[139],"emerges":[140],"good":[143],"lipid-lowering":[144],"in":[146],"patients,":[148],"particularly":[149],"for":[150],"hypertriglyceridemia":[153],"features":[156],"metabolic":[159],"syndrome.":[160]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}